NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

NCT05780437

CompletedPhase 3

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Conditions: COVID-19

Interventions: AZD7442, Placebo, Remdesivir

Countries: United States, Denmark, Greece, Poland, Singapore, Spain, Switzerland, Uganda

This study looks at the safety and effectiveness of AZD7442 in treating COVID-19 in people who have been hospitalized with the infection. Participants in the study will be treated with either a AZD7442 plus current standard of care (SOC), or with placebo plus current SOC. This is ACTIV-3/TICO Treatment Trial H4.

Eligibility overview

Sex: ALL

Age: 18 Years to

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

• Refer to the master protocol (NCT04501978)

Exclusion Criteria:

* Refer to the master protocol (NCT04501978)
* Additional Exclusion Criteria:

  * Pregnant women
  * Nursing mothers
  * Women of child-bearing potential who are unwilling to acknowledge the strong advice to abstain from sexual intercourse with men or practice appropriate contraception through the entire 18 months of the study
  * Men who are unwilling to acknowledge the strong advice to abstain from sexual intercourse with women of child-bearing potential or to use barrier contraception through the entire 18 months of the study.
* In addition, prior to the initial futility assessment which is performed when approximately 150 participants have been enrolled on AZD7442 and 150 on placebo, patients on high-flow oxygen or non-invasive ventilation (category 5 of the pulmonary ordinal outcome) will be excluded. These patients may be eligible for the trial if the initial futility assessment is passed by this agent.
Locations (124)
  • Tucson, Arizona, United States
  • Tucson, Arizona, United States
  • Chula Vista, California, United States
  • Fresno, California, United States
  • La Mesa, California, United States
  • Loma Linda, California, United States
  • Long Beach, California, United States
  • Los Angeles, California, United States
  • Los Angeles, California, United States
  • Los Angeles, California, United States
  • Mather, California, United States
  • Newport Beach, California, United States
  • San Diego, California, United States
  • San Francisco, California, United States
  • San Francisco, California, United States
  • San Francisco, California, United States
  • Stanford, California, United States
  • Torrance, California, United States
  • Aurora, Colorado, United States
  • Denver, Colorado, United States
  • Denver, Colorado, United States
  • West Haven, Connecticut, United States
  • Washington D.C., District of Columbia, United States
  • Washington D.C., District of Columbia, United States
  • Bay Pines, Florida, United States
  • Clearwater, Florida, United States
  • Gainesville, Florida, United States
  • Hollywood, Florida, United States
  • Miami, Florida, United States
  • Tampa, Florida, United States
  • + 94 more on CT.gov